Prostatype Genomics AB (OSTO:PROGEN) Current Deferred Taxes Liabilities : kr0.00 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Prostatype Genomics AB's current deferred tax liabilities for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Prostatype Genomics AB Current Deferred Taxes Liabilities Historical Data

The historical data trend for Prostatype Genomics AB's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Current Deferred Taxes Liabilities Chart

Prostatype Genomics AB Annual Data

Trend

Jun18

Jun19

Dec21

Dec22

Dec23

Dec24

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Prostatype Genomics AB Semi-Annual Data
	Jun18	Jun19	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial						-	-	-	-	-

Prostatype Genomics AB Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gustaf III:s Boulevard 34, Solna, SWE, 169 73

Website

https://www.prostatypegenomics.com

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB Headlines

No Headlines